Titanium Breast Marker Lawsuit 2026: Settlements and Claims

Never Miss a Lawsuit Update

Mark Lawfold as a Preferred Source so you never miss a settlement deadline or new filing.

The titanium breast marker lawsuit is picking up speed in 2026 as hundreds of women take legal action against device manufacturers. These tiny metal clips, placed during breast biopsies to mark tissue sites, have caused serious problems for many patients. Reports of chronic pain, clip migration through breast tissue, allergic reactions, and the need for additional surgeries are driving a wave of new claims.

If you had a titanium marker placed during a breast biopsy and experienced complications, you may be eligible for compensation. This article covers everything you need to know: which manufacturers face legal action, what settlement amounts might look like, who qualifies, how to file, and what the 2026 litigation timeline holds.

You might also find this useful — Update Streaming Lawsuit 2026: Settlement and Payout Info

Thousands of adverse events have been reported to the FDA. Yet many women still don’t know their pain and complications trace back to these tiny clips.

Titanium Breast Marker Lawsuit

A titanium breast marker lawsuit is a product liability claim filed by women who suffered injuries from small titanium clips placed in their breast tissue during or after a biopsy. These lawsuits argue that manufacturers sold defective devices and failed to warn patients about known risks.

The clips are meant to be permanent. They sit in breast tissue so radiologists can locate biopsy sites on future mammograms. For many women, they work without issue. But for a growing number of patients, the clips become a source of ongoing pain, inflammation, and tissue damage.

Lawsuits target the companies that designed, manufactured, and marketed these clips. The core legal claims include design defect, manufacturing defect, and failure to warn. Plaintiffs argue that manufacturers knew about complications but did not adequately disclose them.

Most cases are handled on a contingency basis. That means patients pay nothing upfront and only owe attorney fees if they win.

As of early 2026, the number of filed cases continues to grow. Attorneys across the country are actively reviewing new claims from women with documented complications.

Titanium Breast Marker Lawsuit 2026

The titanium breast marker lawsuit in 2026 is entering a new phase of litigation activity. Case filings accelerated throughout 2025, and legal experts expect the pace to increase this year as more women connect their symptoms to these devices.

Several things are happening in 2026. Courts are consolidating related cases for efficiency. Attorneys are building evidence through expert medical testimony and FDA adverse event data. Early discovery is underway in key jurisdictions.

Key 2026 milestones to watch:

• Potential MDL consolidation ruling expected mid-2026
• First bellwether trial selections could begin late 2026
• Statute of limitations deadlines approaching in some states
• Ongoing FDA review of adverse event reports

The legal landscape has shifted since 2024 when most of these claims were still in the early investigation phase. Now, with enough cases filed and evidence gathered, the litigation is moving toward more structured proceedings.

Women who haven’t yet filed should pay close attention to their state’s filing deadlines. Some states have a two-year statute of limitations from the date of injury or discovery. Waiting too long could mean losing the right to sue entirely.

2026 may also be the year that manufacturers begin settlement discussions, depending on how early court proceedings unfold.

Breast Biopsy Marker Lawsuit

A breast biopsy marker lawsuit covers any legal claim involving marker clips placed during breast biopsy procedures, not just titanium ones. However, titanium clips are at the center of most litigation because they are the most commonly used material.

During a breast biopsy, doctors insert a small marker clip at the biopsy site. This helps identify the exact location on future imaging. The procedure takes minutes, and patients are told the clip is safe and will not cause problems.

For many women, that turned out to be wrong. Reports of complications started surfacing years ago, but the issue gained momentum when patients began sharing their experiences online and in medical forums.

The breast biopsy marker lawsuit category is broader than just one manufacturer or one product. It includes claims against multiple companies that produce different clip designs. But titanium-based clips account for the vast majority of filed complaints and lawsuits.

Patients who experienced problems with any type of biopsy marker should review their medical records to identify the specific device used. That information is critical for determining which manufacturer to pursue.

Key Takeaway: The titanium breast marker lawsuit is accelerating in 2026, with potential MDL consolidation and bellwether trial selections on the horizon, making this a critical year for women considering legal action.

Titanium Breast Marker Settlement

No titanium breast marker settlement has been finalized on a mass scale as of early 2026. The litigation is still in its early-to-mid stages, which means global settlement talks have not yet produced confirmed payouts.

That said, individual settlements in product liability cases involving medical devices often happen before a mass resolution. Some plaintiffs who filed early may have already received confidential settlement offers. Those amounts are typically not disclosed to the public.

Based on comparable medical device lawsuits, legal analysts have projected potential settlement ranges.

These are estimates, not guarantees. Every case is different. The actual settlement value depends on the severity of your injury, your medical documentation, the specific manufacturer, and how the overall litigation progresses.

Think of it like a car accident claim. A fender bender pays differently than a rollover crash. The same logic applies here. More serious injuries with clear medical evidence command higher payouts.

Settlement timelines in mass tort cases typically run 2 to 5 years from the first major filings. Given that significant filing activity began in 2024, settlements could emerge as early as late 2026 or 2027 for some plaintiffs.

Breast Biopsy Marker Settlement Amounts

Breast biopsy marker settlement amounts will vary widely based on individual case details. There is no one-size-fits-all number, and anyone promising a specific dollar figure before the litigation is resolved is getting ahead of the facts.

Several factors determine what a claim is worth:

• Type and severity of injury: Clip migration requiring surgical removal is worth more than localized soreness.
• Medical documentation: Clear records linking complications to the marker strengthen your case.
• Number of surgeries: Women who needed the clip surgically removed or who required corrective procedures will see higher values.
• Lost wages and quality of life: If complications prevented you from working or performing daily activities, those losses add up.
• Manufacturer behavior: Evidence that a company hid risks or ignored complaints increases potential damages.

In past medical device mass torts, settlement values have ranged dramatically. The transvaginal mesh litigation, for example, saw individual payouts from $30,000 to over $500,000 depending on case severity.

Breast marker cases are newer and smaller in scale, so direct comparisons aren’t perfect. But the legal framework is similar. Plaintiffs with strong medical records and documented harm stand to recover the most.

Quick Fact: Women who kept copies of their operative reports, pathology results, and post-procedure imaging are in the strongest position to pursue maximum compensation.

Who Qualifies for Breast Marker Lawsuit

You may qualify for a breast marker lawsuit if you had a titanium marker clip placed during a breast biopsy and later experienced complications that required medical attention.

Here are the general eligibility criteria attorneys are using:

• You had a breast biopsy marker clip implanted (any brand)
• You experienced one or more complications afterward: pain, swelling, migration, infection, or allergic reaction
• You sought medical treatment for those complications
• You can identify the specific marker device used (your medical records should have this)
• Your claim falls within your state’s statute of limitations

Not every woman who received a titanium clip qualifies. If you had a clip placed and experienced zero issues, there’s no basis for a claim. The lawsuit requires proof of injury.

Women who had their clips removed due to complications may have especially strong cases. The removal surgery itself represents additional harm and medical expense directly caused by the defective device.

Key Takeaway: Settlement amounts will depend on injury severity, medical documentation, and manufacturer behavior, with projected ranges from $25,000 to over $500,000 in the most serious cases.

Titanium Clip Breast Side Effects

Titanium clip breast side effects range from mild discomfort to severe complications requiring surgical intervention. While manufacturers marketed these clips as safe and inert, a significant number of women have reported otherwise.

The most commonly reported side effects include:

• Chronic pain at the clip site that persists months or years after placement
• Inflammation and swelling in surrounding breast tissue
• Clip migration where the marker moves from its original placement site
• Granuloma formation: a mass of inflamed tissue that develops around the clip
• Allergic reaction to the titanium material
• Infection at the insertion site
• Nerve damage causing shooting pain, numbness, or tingling

Some of these side effects appear within days or weeks of the biopsy. Others don’t show up for months or even years, making it difficult for women to connect their symptoms to the marker clip.

Doctors don’t always consider the clip as a potential source of problems. Many women report being told their pain is “normal” or unrelated. This delayed recognition has left some patients suffering unnecessarily for years before getting answers.

If you’ve experienced any of these symptoms after a breast biopsy, request a copy of your operative report. It will identify the exact clip that was placed and the manufacturer. That information is the first step toward understanding whether the device is responsible.

Titanium Breast Marker Complications

Titanium breast marker complications go beyond simple side effects. In the most serious cases, these complications have required multiple surgeries, caused permanent tissue damage, and significantly affected patients’ quality of life.

The medical complications fall into several categories:

What makes these complications particularly frustrating is that many women were never warned they could happen. Informed consent forms for breast biopsies typically mention the marker clip only briefly, if at all.

The body treats the titanium clip as a foreign object. In some patients, the immune system reacts aggressively. This creates a cycle of inflammation, tissue damage, and pain that doesn’t resolve on its own.

For women with titanium hypersensitivity, the reaction can extend beyond the breast. Systemic symptoms like fatigue, joint pain, brain fog, and skin rashes have been reported. These whole-body reactions are less well-documented but appear in a growing number of patient accounts and medical case studies.

Breast Marker Clip Migration

Breast marker clip migration occurs when the titanium clip moves from its original placement site to another location in the breast tissue. This is one of the most common and most documented complications.

Migration can happen gradually over weeks or months. In some cases, clips have moved several centimeters from where they were placed. This creates multiple problems.

Why migration matters:

For more context, see Laura Loomer Bill Maher Lawsuit 2026: Full Case Updates

• The clip no longer marks the correct biopsy site, making it useless for its intended purpose
• A migrated clip can cause pain in surrounding tissue, muscles, or nerves
• It may interfere with future mammogram readings, creating false results
• Surgical removal becomes more difficult when the clip has moved

Radiologists have reported finding clips in unexpected locations during routine mammograms. In some cases, the clip moved so far that it was initially mistaken for a new mass, causing unnecessary alarm and additional testing.

If your mammogram shows that a previously placed clip is no longer in its original spot, that’s a red flag. Document this finding and bring it to your attorney’s attention. Migration evidence is among the strongest proof of device failure in these lawsuits.

Key Takeaway: Titanium breast marker complications include migration, granuloma formation, titanium hypersensitivity, and chronic pain, and many women were never warned these risks existed before their biopsy.

Breast Marker Clip Pain After Biopsy

Breast marker clip pain after biopsy is the symptom most commonly reported by women in these lawsuits. While some discomfort after a biopsy is expected, persistent or worsening pain weeks or months later is not normal.

The pain presents differently for different women:

• Sharp, stabbing sensations near the clip site
• Burning or tingling that radiates through the breast
• Deep aching that doesn’t respond to over-the-counter pain medication
• Pain triggered by pressure, such as wearing a bra or lying on that side

Many women describe the pain as coming and going at first, then becoming constant. Some report that the pain got worse during temperature changes or physical activity.

Doctors don’t always link post-biopsy pain to the clip. Standard medical guidance says biopsy pain should resolve within a week or two. When it doesn’t, patients often face a frustrating cycle of tests and referrals that don’t identify the clip as the cause.

Quick Fact: According to FDA adverse event reports, pain is the single most frequently cited complaint in breast biopsy marker filings in the MAUDE database.

If your pain began after a breast biopsy and no other cause has been identified, the marker clip should be investigated. Request imaging specifically focused on the clip’s position and the surrounding tissue. Any signs of inflammation, granuloma, or migration near the clip support a connection.

Women who endured months or years of unexplained breast pain before learning the clip was responsible often have strong cases. The delay in diagnosis itself can be part of the damages claimed.

Titanium Allergy Breast Marker

A titanium allergy related to a breast marker is a less recognized but potentially severe complication. While titanium is considered biocompatible for most people, a subset of the population develops hypersensitivity reactions to the metal.

Symptoms of a titanium allergy reaction can include:

• Localized pain, redness, and swelling at the clip site
• Skin rashes or hives appearing elsewhere on the body
• Chronic fatigue and brain fog
• Joint pain not explained by other conditions
• Persistent low-grade inflammation markers in bloodwork

Testing for titanium sensitivity is possible through a blood test called the MELISA test (Memory Lymphocyte Immunostimulation Assay). This test measures your immune system’s reaction to titanium and other metals. It’s considered the gold standard for diagnosing metal hypersensitivity.

A positive MELISA test is powerful evidence in a lawsuit. It proves your body reacts to the very material the manufacturer chose to use. This directly supports failure-to-warn claims, especially since most biopsy consent forms don’t mention the possibility of titanium allergy.

Not every attorney or doctor is familiar with this test. If you suspect a titanium reaction, specifically ask for a MELISA referral. The result can make or break your case’s value.

Titanium Breast Marker MDL

A titanium breast marker MDL (Multidistrict Litigation) would consolidate all federal lawsuits involving titanium breast marker clips into a single court and before a single judge. As of early 2026, a formal MDL has not yet been established, but legal experts consider it likely.

Here’s how an MDL works:

• Individual lawsuits filed across different federal courts get transferred to one judge
• The judge handles pretrial matters like discovery, expert witnesses, and motions for all cases together
• This prevents contradictory rulings and speeds up the process
• Each plaintiff still retains their own case and can settle individually

Think of an MDL like a group project in school. Everyone works on shared tasks together, but each person still gets their own grade. The shared work includes things like deposing company executives and reviewing internal documents. Individual outcomes depend on each person’s specific facts.

Quick Fact: The Judicial Panel on Multidistrict Litigation (JPML) is the body that decides whether to create an MDL and where to send it. A motion to create a titanium breast marker MDL could be filed at any time.

Key Takeaway: A titanium allergy confirmed by MELISA testing can significantly strengthen a breast marker lawsuit claim, and a formal MDL consolidation may occur in 2026, streamlining how these cases are handled.

How to File a Titanium Breast Marker Claim

Filing a titanium breast marker claim involves several steps, and the process is more straightforward than most people expect. You don’t need to understand complex legal procedures. An experienced attorney handles the heavy lifting.

Step-by-step process:

1. Gather your medical records. Get your biopsy operative report, pathology report, and any follow-up imaging. These identify the specific clip used.
2. Document your complications. Collect records from every doctor visit, procedure, or treatment related to your symptoms.
3. Identify the manufacturer. Your operative report should name the marker device. If it doesn’t, your hospital’s medical records department can help.
4. Contact a mass tort attorney. Look for firms with experience in medical device litigation.
5. Review and sign a retainer agreement. Most firms work on contingency, meaning no upfront cost.
6. Your attorney files the claim. They handle all court filings, discovery, and negotiations.

You don’t need to be a legal expert. You need your medical records and a few hours to talk with an attorney. They’ll evaluate whether you have a viable claim and explain what to expect.

The most common mistake women make is waiting too long. Statutes of limitations are real deadlines, and missing them means losing your right to sue permanently.

Breast Marker Lawsuit Eligibility 2026

Breast marker lawsuit eligibility in 2026 depends on three main factors: what happened to you, when it happened, and whether you can prove it.

Here’s a quick eligibility checklist:

• You had a titanium breast biopsy marker clip implanted
• You developed complications (pain, migration, allergy, infection, or need for removal surgery)
• Your complications are documented in medical records
• You are within your state’s statute of limitations
• You can identify the specific device and manufacturer

State statute of limitations examples:

The discovery rule is important. In many states, the clock starts when you knew or should have known that the clip caused your injury. Not when the clip was placed. This means women who only recently connected their symptoms to the marker may still be within the filing window.

If you’re unsure whether you qualify, the fastest way to find out is a free case evaluation with a mass tort attorney. These consultations cost nothing and take about 15 to 20 minutes.

Titanium Marker Manufacturers Lawsuit

Titanium marker manufacturers facing lawsuits include several of the biggest medical device companies in the world. These are not small startups. They are well-funded corporations with extensive legal teams.

The primary manufacturers named in breast marker lawsuits include:

Plaintiffs argue these companies had a duty to test their products thoroughly and warn patients and doctors about risks. Internal company documents and pre-market testing data are central to these claims.

In product liability law, manufacturers are held to a high standard. They must prove their products are reasonably safe for their intended use. If evidence shows that a company knew about migration risks or allergic reactions but chose not to update warnings or redesign the clip, that’s a strong case for failure to warn.

Quick Fact: Several of these companies received 510(k) clearance for their markers, which means the FDA allowed them on the market based on similarity to existing devices rather than through rigorous new testing. That clearance pathway is itself a point of contention in the lawsuits.

Key Takeaway: Major manufacturers including Hologic, BD, and Merit Medical face lawsuits, and the 510(k) clearance process these devices used is a key point of criticism in the litigation.

Breast Biopsy Marker Recall

As of early 2026, there has been no formal FDA recall of titanium breast biopsy markers. This is a source of frustration for many patients and their attorneys.

A recall would require the FDA to determine that a specific product poses an unreasonable risk of harm. Despite the growing number of adverse event reports, the FDA has not taken that step for titanium breast markers as a category.

That doesn’t mean the devices are safe. It means the regulatory process is slow.

Don't miss this — Green and Sons Football Lawsuit 2026: Full Claim Update

What has happened:

• Individual lot recalls have occurred for manufacturing quality issues (not safety-related)
• Some manufacturers have quietly updated their labeling to include additional warnings
• The FDA’s MAUDE database contains a growing number of adverse event reports for breast markers
• No broad safety recall has been issued

The absence of a recall doesn’t weaken a lawsuit. Product liability cases don’t require a recall to proceed. Plenty of successful medical device lawsuits have been won against products that were never formally recalled. The litigation itself often exposes the problems that a recall should have addressed.

Patients should not wait for a recall to take action. The legal process works independently of FDA regulatory decisions.

Titanium Breast Marker FDA Complaints

Titanium breast marker FDA complaints are filed through the agency’s MAUDE (Manufacturer and User Facility Device Experience) database. This system collects reports of adverse events involving medical devices from patients, healthcare providers, and manufacturers.

The number of MAUDE reports related to breast biopsy marker clips has increased sharply in recent years. Reports describe:

• Persistent pain at the marker site
• Clip migration detected on follow-up mammograms
• Allergic and inflammatory reactions
• Need for surgical removal
• Interference with subsequent breast imaging

How to file an FDA complaint:

• Visit the FDA’s MedWatch reporting system
• Complete the voluntary reporting form (FDA Form 3500)
• Include your device details, symptoms, and treatment information
• Your report becomes part of the public MAUDE database

Filing an FDA complaint serves two purposes. First, it creates a public record that regulators can use to evaluate whether action is needed. Second, it provides supporting evidence for the broader litigation. Attorneys use MAUDE data to show that the manufacturer knew or should have known about problems.

If you experienced complications from a breast marker clip, filing a MAUDE report is a concrete step you can take today. It costs nothing and takes about 20 minutes.

Breast Biopsy Clip Lawsuit

A breast biopsy clip lawsuit is the broader term for legal claims involving any type of clip placed during a breast biopsy. While titanium clips dominate the litigation, claims can involve stainless steel clips, polymer markers, and hydrogel-based devices.

The legal theories are the same regardless of material:

• The device was defectively designed
• The device was improperly manufactured
• The manufacturer failed to warn about known risks
• The manufacturer was negligent in testing and monitoring

What separates a strong case from a weak one:

Women who had clips placed and later removed due to problems are in the strongest position. The removal surgery itself creates a clear chain of evidence: the clip caused harm, and removal was medically necessary.

If you still have your clip in place and are experiencing symptoms, don’t assume you need to have it removed before filing a claim. An attorney can evaluate your case based on your current symptoms, medical records, and imaging.

Key Takeaway: Filing an FDA complaint through the MAUDE database creates public evidence supporting the broader litigation, and you do not need to wait for a formal recall to take legal action against breast marker manufacturers.

Frequently Asked Questions

How much money can I get from a titanium breast marker lawsuit?

Estimated payouts range from $25,000 to $500,000 or more depending on injury severity.

Cases involving surgical clip removal and documented complications tend to receive the highest settlements.

No final mass settlement amounts have been confirmed as of 2026.

What are the symptoms of a titanium breast marker reaction?

Common symptoms include chronic pain, swelling, inflammation, and clip migration visible on mammograms.

Some women experience systemic reactions like fatigue, joint pain, and skin rashes from titanium hypersensitivity.

Symptoms can appear within days or take months to develop.

Is there a deadline to file a titanium breast marker claim in 2026?

Yes, every state has a statute of limitations, typically 2 to 3 years from the date you discovered the injury.

The discovery rule in most states starts the clock when you learned the clip caused your symptoms, not when it was placed.

Waiting too long could permanently bar your claim.

Which breast biopsy marker brands are included in lawsuits?

Brands from Hologic, BD (Becton Dickinson), Devicor, Merit Medical, and Bard are among those named.

Specific products include Gel Mark Ultra, UltraClip, SecurMark, CorMark, and Mammotome marker systems.

Your operative report should identify which device was used.

Do I need to have the titanium clip removed to qualify for a lawsuit?

No, you do not need to have the clip removed to file a claim.

Documented complications like pain, migration, or allergic reactions are sufficient for many attorneys to accept your case.

Having the clip removed does strengthen a case by providing clear evidence of harm.

This year may be the turning point for women affected by titanium breast marker clips. The litigation is gaining momentum, manufacturers are facing real accountability, and the window to file remains open.

Check your medical records. Identify the clip that was used. Talk to a mass tort attorney about your options.

If you experienced pain, migration, or other complications after a breast biopsy, you have every reason to explore your legal rights before deadlines close

See also: Golf Lawsuit Q3 2026: Settlements, Deadlines and Payouts

Never Miss a Lawsuit Update

Mark Lawfold as a Preferred Source so you never miss a settlement deadline or new filing.